These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3464851)
1. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma]. Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H; Schieder K; Neunteufel W; Bieglmayer C Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933 [TBL] [Abstract][Full Text] [Related]
4. [Advances regarding tumor markers in bladder cancer]. Moreno Sierra J; Chicharro Almarza GJ; Torronteras Santiago JM; Ortega Heredia MD; Maestro de las Casas ML; Silmi Moyano A; Resel Estévez L Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884 [TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction. Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354 [TBL] [Abstract][Full Text] [Related]
6. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage]. Rodríguez Martínez JJ; Escaf Barmadah S; Allende MT; Raigoso P; Martín Benito JL; Pérez García FJ; Fernández Gómez JM Arch Esp Urol; 2000; 53(1):1-6. PubMed ID: 10730418 [TBL] [Abstract][Full Text] [Related]
7. [CEA and TPA in bladder carcinoma]. Latella G; Ciarniello P; Fusco A; Liberti M; Gentile V; De Berardinis E; Von Heland M Minerva Med; 1986 Mar; 77(13):505-6. PubMed ID: 3703342 [No Abstract] [Full Text] [Related]
8. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen]. Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198 [TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma]. Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Libertucci D; Coni F; Oliaro A Minerva Med; 1987 Mar; 78(6):373-5. PubMed ID: 3470632 [TBL] [Abstract][Full Text] [Related]
10. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer]. Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804 [TBL] [Abstract][Full Text] [Related]
11. Serum CA 19-9 and CA 50 antigens in hemodialysis patients. Docci D; Pistocchi E; Turci F; Baldrati L; Urbini S; Scaioli S Clin Nephrol; 1987 Apr; 27(4):179-81. PubMed ID: 3472698 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder. Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331 [TBL] [Abstract][Full Text] [Related]
13. [Serial changes in serum CA 19-9 levels in pancreatic cancer]. Saito K; Tajiri H; Yoshimori M; Hijikata A; Ohkura H; Nakamura K; Ozaki H Gan No Rinsho; 1987 Aug; 33(9):1057-60. PubMed ID: 3476762 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947 [TBL] [Abstract][Full Text] [Related]
15. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder. Vogel J; Oehr P; Maisey R; Adolphs HD Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597 [TBL] [Abstract][Full Text] [Related]
16. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis]. Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111 [TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related]
18. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach]. Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528 [No Abstract] [Full Text] [Related]
19. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen]. Olsson NO; Crimet-Montange D; Martin F Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449 [TBL] [Abstract][Full Text] [Related]
20. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. el-Ahmady O; Halim AB; el-Din AG Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]